Cargando…
Survival analysis of stage II gastric cancer patients after D2 gastrectomy: a Chinese people-based research
OBJECTIVE: The benefit of adjuvant chemotherapy is still controversial for stage II gastric cancer patients. This study aims to identify prognostic factors to guide individualized treatment for stage II gastric cancer patients. METHODS: We retrospectively reviewed 1121 stage II gastric cancer patien...
Autores principales: | Deng, Zi-Jian, Nie, Run-Cong, Lu, Jun, Chen, Xi-Jie, Xiang, Jun, Huang, Chang-Ming, Chen, Ying-Bo, Peng, Jun-Sheng, Chen, Shi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496033/ https://www.ncbi.nlm.nih.gov/pubmed/34620108 http://dx.doi.org/10.1186/s12876-021-01937-9 |
Ejemplares similares
-
Retrieval of 30 Lymph Nodes Is Mandatory for Selected Stage II Gastric Cancer Patients
por: Chen, Yong-He, et al.
Publicado: (2021) -
Tumor Size Is a Critical Factor in Adjuvant Chemotherapy for T(3-4a)N0M0 Gastric Cancer Patients after D2 Gastrectomy
por: Chen, Shi, et al.
Publicado: (2017) -
Additional gastrectomy in early-stage gastric cancer after non-curative endoscopic resection: a meta-analysis
por: Nie, Run-Cong, et al.
Publicado: (2019) -
Selective Gastric Cancer Patients with Peritoneal Seeding Benefit from Gastrectomy after Palliative Chemotherapy: A Propensity Score Matching Analysis
por: Yuan, Shu-Qiang, et al.
Publicado: (2017) -
Worse Survival of Patients With T1 Stage II Gastric Cancer Following Radical Gastrectomy
por: Lee, Hayemin, et al.
Publicado: (2023)